An Empowered, Clinically-Viable Hematopoietic Stem Cell Gene Therapy Approach for the Treatment of Multisystemic Mucopolysaccharidosis Type II

Scientists developed up to clinical readiness a new Hematopoietic Stem Cell (HSC) gene therapy approach for Mucopolysaccharidosis type II that benefitted from a novel highly effective transduction protocol.